PDB Entry - 8STG
(Status - Released)Summary information:
Title: Discovery and clinical validation of RLY-4008, the first highly selective FGFR2 inhibitor with activity across FGFR2 alterations and resistance mutations
PDB DOI: https://doi.org/10.2210/pdb8stg/pdb
Primary publication DOI: https://doi.org/10.1158/2159-8290.CD-23-0475
Entry authors: Valverde, R., Foster, L.
Initial deposition on: 10 May 2023
Initial release on: 7 June 2023
Latest revision on: 25 October 2023
Downloads:
Structure coordinates (PDBx/mmCIF)
Structure coordinates (PDBML)
Structure coordinates (PDB)
X-ray diffraction data (PDBx/mmCIF)
Validation report (mmCIF)
Validation report (XML)
Validation report (PDF)
Links to more resources for 8STG at: